Last reviewed · How we verify
fennel
Fennel, marketed by the University of Karachi, is a drug with a key composition patent expiring in 2028. The primary strength of Fennel lies in its current market presence, leveraging the patent protection to maintain exclusivity. The primary risk is the potential increase in competition post-2028, when the key patent expires.
At a glance
| Generic name | fennel |
|---|---|
| Also known as | Foeniculum vulgare |
| Sponsor | University of Karachi |
| Modality | Biologic |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Ivermectin Safety in Small Children (PHASE2)
- Effect of Breastfeeding Mothers Drinking Fennel Seed Infusion on Infants With Colic (NA)
- Impact of the Inno Cleanse Dietary Supplement on Gut Health and Associated Variables in Healthy Men and Women (NA)
- Effects of Chewing Gum, Fennel, and Ginger Tea on Intestinal Motility and Comfort After Cesarean (NA)
- A Randomized, Placebo Controlled Clinical Study to Assess the Effect of a Blend of Digestive Enzymes and Extracts on Bloating in Adults. (NA)
- Fermented Food - Achars (fermented Pickles) in Pakistan (NA)
- The Effect Of Coffee And Tea Drink On Gis Functions Healing Quality After Surgery in Patients Surgery (NA)
- Effect of Probiotic Toothpaste and Regular Toothpaste on Plaque Levels of Orthodontic Patients (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |